Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

top_ten

Top Ten most popular articles on Pharmafile.com this week

March 2, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Alzheimer's, AstraZeneca, Botox, Celgene, EMA, FDA, Merck, Mylan, Pfizer, Roche, Takeda, ipsen, vaccines

We’re already into March and, trying to put a bad start to the year behind them on Alzheimer’s research, the …
News
endo-international

Endo granted injunction to block blood pressure competitor

March 2, 2018 Medical Communications, Sales and Marketing Endo, QuVa, Vasostrict, blood pressure, pharma, vasopressin

Generics and speciality pharma firm Endo International has revealed that it has been granted a preliminary injunction to block  competitor …
News
shutterstock_92671375

Artificial Cell Technologies CFO accused of stealing nearly $1m in company funds

March 2, 2018 Medical Communications, Sales and Marketing Artificial Cell Technologies, cfo, pharma

A high-ranking C-level executive of a US biotech start-up has been charged with embezzling almost $1 million from the company …
News
david_meek_web

Ipsen: Becoming a “development powerhouse”

March 1, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Insider Interview, ipsen, pharma

Immediately following the release of impressive full year financials, Ipsen CEO David Meek speaks on how the company is hitting …
Feature
11149low_reception_in_darm

Merck/Pfizer’s Bavencio wins slight reprieve after NICE nod

March 1, 2018 Medical Communications, Sales and Marketing Bavencio, Merck, Pfizer, biotech, drugs, pharma, pharmaceutical

Just two weeks ago, Merck KGaA and Pfizer were hit with a major setback for their PD-L1 immunotherapy, Bavencio, after …
News
mylan_building

Mylan looks to muscle in on Allergan’s Botox territory

March 1, 2018 Sales and Marketing Botox, Mylan, Revance Therapeutics, biotech, drugs, epipen, pharma, pharmaceutical

Mylan announced, alongside its financials, that it had signed a global collaboration and licensing agreement with Revance Therapeutics to partner …
News
celgene_1_02

FDA refuses to review Celgene’s ozanimod in multiple sclerosis

February 28, 2018 Research and Development, Sales and Marketing Celgene, FDA, multiple sclerosis, ozanimod, pharma

Celgene has been dealt a heavy blow, revealing that the FDA has rejected its New Drug Application for its sphingosine …
News

AstraZeneca creates biotech spin-off, $250m in bank

February 28, 2018 Research and Development, Sales and Marketing AstraZeneca, Viela, biotech, drugs, pharma, pharmaceutical

Biotechs created from big pharma companies tend to have an easier start to life than most, and this is definitely …
News
pharmafocus_march_2018_cover

Pharmafocus March 2018 is available to read online now!

February 28, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, brexit, drug safety, pharma, real world data

Though never truly out of vogue, the drug pricing debate has flared up again with the White House’s release of …
News
dna

Generation Bio backed with $100m financing round

February 28, 2018 Research and Development, Sales and Marketing Generation Bio, biotech, drugs, pharma, pharmaceutical

At the start of year, Generation Bio was revealed to the public, announcing that it had been developing gene therapies …
News
nhs_sign

UK Government announces prescription price hike to record level

February 27, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing NHS, pharma, prescription, price

The UK Government has announced plans to increase prescription charges by 20p, or 2.3%, to a record £8.80, effective 1 …
News

FDA expands indication of Lilly’s Verzenio in advanced breast cancer

February 27, 2018 Manufacturing and Production, Sales and Marketing Cancer, Eli Lilly, FDA, Verzenio, breast cancer, pharma

Eli Lilly is celebrating the news that its cyclin-dependent kinase (CDK) 4 & 6 inhibitor Verzenio (ademaciclib) has received approval …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 23, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Alzheimer's, AstraZeneca, Eylea, FDA, Microsoft, Regeneron, Shire, Tremfya, eurordis, multiple myeloma, rare disease

It’s the last Friday of February, and it’s time for another run-down of the most popular stories of the week. …
News
gilead-sciences

Gilead seals $3bn deal, hoping for off-the-shelf CAR-T

February 23, 2018 Medical Communications, Sales and Marketing CAR-T, Gilead, Kite, Sangamo Therapeutics, biotech, drugs, pharma, pharmaceutical

The expense and laborious process involved in bringing CAR-T therapies to patients was used a key reason for the high …
News
aaa

Insider Interview: Allergan’s R&D Chief on plans to be “the headache company”

February 22, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, David Nicholson, Insider Interview, migraine, pharma

Speaking to Pharmafocus , David Nicholson, Chief R&D Officer at Allergan, revealed that the company has big plans in the …
Feature
The Gateway to Local Adoption Series

Latest content

How will biomarker-led diagnostics reshape respiratory medicine?

October 11, 2026

Five Facts about COPD

October 11, 2026

“That gap between innovation and delivery was what stood out to me most”

October 11, 2026

Agentic commercial: how AI creates dialogue with HCPs and patients to help medicines reach them faster

October 11, 2026

Fortysomethings’ non-attendance at NHS Health Checks raises concerns, says study

October 11, 2026